FDA Announces Joint Meeting of Advisory Committees to Discuss Nonprescription Drugs and Anesthetic Safety

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of its Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee to discuss nonprescription drugs and anesthetic safety, with the meeting to take place on an unspecified date.